Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

0.7009

-0.0088 (-1.24%)

At close: Jan 6, 2026, 4:00 PM EST

0.6750

-0.0259 (-3.70%)

After-hours: Jan 6, 2026, 7:56 PM EST

Lexaria Bioscience Employees

Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.

Employees

7

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$100,846

Profits / Employee

-$1,700,263

Market Cap

17.44M

Employees Chart

Employees History

Date	Employees	Change	Growth
Aug 31, 2025	7	0	-
Aug 31, 2024	7	2	40.00%
Aug 31, 2023	5	-2	-28.57%
Aug 31, 2022	7	1	16.67%
Aug 31, 2021	6	2	50.00%
Aug 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

LEXX News

7 days ago - Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 - Accesswire
14 days ago - Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus - Benzinga
14 days ago - Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4 - Accesswire
21 days ago - Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
22 days ago - Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Accesswire
7 weeks ago - Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Accesswire
3 months ago - Lexaria Bioscience Corp. Provides Strategic Update - Accesswire
3 months ago - Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Accesswire